Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

SHE:002275 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,050	1,058	1,266	1,478	1,362
Short-Term Investments	-	43.4	-	-	25.21
Trading Asset Securities	626.15	304.69	161.24	221.77	355.34
Cash & Short-Term Investments	1,676	1,406	1,427	1,699	1,742
Cash Growth	19.17%	-1.45%	-16.03%	-2.47%	38.93%
Accounts Receivable	527.3	458.33	542.51	413.03	367.38
Other Receivables	118.06	4.39	57.58	9.1	13.59
Receivables	645.36	462.72	600.09	422.13	380.97
Inventory	208.29	255.96	244.9	284.15	194.37
Other Current Assets	35.18	71.17	25.06	48.4	62.1
Total Current Assets	2,565	2,196	2,297	2,454	2,380
Property, Plant & Equipment	1,111	1,155	1,227	1,313	1,300
Long-Term Investments	94.45	299.09	132.61	4.21	4.2
Goodwill	5.7	5.7	5.7	5.7	5.7
Other Intangible Assets	141.55	153.56	168.28	178.36	166.55
Long-Term Deferred Tax Assets	10.2	9.33	8.53	11.35	8.83
Long-Term Deferred Charges	102.44	117.04	125.76	128.8	16.79
Other Long-Term Assets	202.44	-	-	0.03	0.04
Total Assets	4,232	3,936	3,965	4,096	3,882
Accounts Payable	191.55	201.38	133.92	180.24	91.56
Accrued Expenses	33.14	160.61	160.45	123.86	101.77
Short-Term Debt	325.26	274.2	140.01	251.68	150.08
Current Portion of Long-Term Debt	118.01	104.54	107.57	33.04	6.31
Current Portion of Leases	-	14.72	11.81	9.52	9.81
Current Income Taxes Payable	64.3	25.95	71.79	38.13	27.17
Current Unearned Revenue	98.06	75.99	170.01	132.79	163.65
Other Current Liabilities	165.15	36.45	51.38	59.98	38.97
Total Current Liabilities	995.46	893.83	846.94	829.23	589.31
Long-Term Debt	121.5	73.92	128.03	226.93	233.35
Long-Term Leases	28.86	60.95	78.45	87.93	5.14
Long-Term Unearned Revenue	63.15	89.04	97.85	111.22	94.9
Long-Term Deferred Tax Liabilities	0.15	-	0.33	0.73	0.58
Other Long-Term Liabilities	13.32	1.34	-	-	-
Total Liabilities	1,222	1,119	1,152	1,256	923.27
Common Stock	587.57	587.57	587.57	590.2	590.2
Additional Paid-In Capital	672.09	669.24	638.76	685.78	690.25
Retained Earnings	1,781	1,583	1,573	1,767	1,884
Treasury Stock	-	-	-	-204	-204
Comprehensive Income & Other	-31.12	-22.72	14.13	0.64	-1.14
Shareholders' Equity	3,010	2,817	2,813	2,840	2,959
Total Liabilities & Equity	4,232	3,936	3,965	4,096	3,882
Total Debt	593.63	528.33	465.88	609.1	404.68
Net Cash (Debt)	1,082	877.86	961.07	1,090	1,338
Net Cash Growth	23.27%	-8.66%	-11.86%	-18.50%	34.86%
Net Cash Per Share	1.85	1.50	1.63	1.90	2.32
Filing Date Shares Outstanding	572.24	587.57	587.57	575.27	575.27
Total Common Shares Outstanding	572.24	587.57	587.57	575.27	575.27
Working Capital	1,569	1,302	1,450	1,625	1,791
Book Value Per Share	5.26	4.79	4.79	4.94	5.14
Tangible Book Value	2,863	2,658	2,639	2,656	2,787
Tangible Book Value Per Share	5.00	4.52	4.49	4.62	4.84
Buildings	-	993.15	997.12	1,053	1,029
Machinery	-	81.92	76.86	76.54	563.54
Construction In Progress	-	21.24	61.66	105.26	299.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.